HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Shimoyama Selected Research

M Shimoyama Research Topics

Disease

5Cardiomegaly (Heart Hypertrophy)
07/2001 - 10/2000
4Neoplasms (Cancer)
09/2001 - 02/2000
4Lymphoma (Lymphomas)
07/2001 - 01/2000
3Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2011 - 01/2000
3Fibrosis (Cirrhosis)
07/2001 - 10/2000
3Hypertension (High Blood Pressure)
06/2001 - 10/2000
2Pain (Aches)
01/2005 - 09/2001
1Carotid Stenosis (Carotid Artery Stenosis)
12/2015
1Hypotension (Low Blood Pressure)
08/2013
1Burns
04/2010
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2009
1Pneumothorax
10/2005
1Pulmonary Edema
10/2005
1Hyperalgesia
01/2005
1Neuralgia (Stump Neuralgia)
01/2005
1Inflammation (Inflammations)
01/2005
1Esophagitis
11/2001
1Cancer Pain
09/2001
1Cardiotoxicity
08/2001
1Body Weight (Weight, Body)
07/2001
1Hypertrophy
07/2001
1Heart Failure
06/2001
1Coronary Disease (Coronary Heart Disease)
06/2001
1Atrial Fibrillation
06/2001
1Stroke (Strokes)
06/2001
1Respiratory Insufficiency (Respiratory Failure)
04/2001
1Carcinogenesis
01/2001
1Essential Thrombocythemia
11/2000
1Babesiosis (Piroplasmosis)
08/2000
1Hemolysis
08/2000
1Hemorrhage
08/2000
1Peptic Ulcer (Peptic Ulcers)
08/2000
1Parasitemia
08/2000
1Hodgkin Disease (Hodgkin's Disease)
03/2000
1Hypoproteinemia
02/2000
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2000
1Leukemia
02/2000
1Thrombocytopenia (Thrombopenia)
02/2000

Drug/Important Bio-Agent (IBA)

4CalcineurinIBA
07/2001 - 10/2000
3Calcineurin InhibitorsIBA
11/2009 - 10/2000
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2002 - 01/2000
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2002 - 01/2000
3Vincristine (Oncovin)FDA LinkGeneric
09/2002 - 01/2000
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
07/2001 - 10/2000
2Prednisone (Sone)FDA LinkGeneric
09/2002 - 03/2000
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
09/2002 - 05/2001
2RNA (Ribonucleic Acid)IBA
07/2001 - 11/2000
2Tacrolimus (Prograf)FDA LinkGeneric
02/2001 - 10/2000
2CalciumIBA
02/2001 - 10/2000
2SaltsIBA
02/2001 - 10/2000
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
11/2009
1SodiumIBA
10/2005
1sivelestatIBA
10/2005
1Synapsins (Synapsin I)IBA
01/2005
1CarrageenanIBA
01/2005
1Endothelin-1 (Endothelin 1)IBA
01/2005
1LenograstimIBA
09/2002
1Lansoprazole (Prevacid)FDA LinkGeneric
11/2001
1Morphine (MS Contin)FDA LinkGeneric
09/2001
1Docetaxel (Taxotere)FDA Link
08/2001
1Protein Kinases (Protein Kinase)IBA
07/2001
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2001
1DNA (Deoxyribonucleic Acid)IBA
07/2001
1Ventricular MyosinsIBA
06/2001
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
06/2001
1Mitochondrial DNA (mtDNA)IBA
06/2001
1Adenine NucleotidesIBA
06/2001
1DiureticsIBA
06/2001
1Pharmaceutical PreparationsIBA
04/2001
1tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA
04/2001
1Antineoplastic Agents (Antineoplastics)IBA
02/2001
1Fas Ligand Protein (Fas Ligand)IBA
01/2001
1SteroidsIBA
08/2000
1AntibodiesIBA
08/2000
1Clindamycin (Cleocin)FDA LinkGeneric
08/2000
1GlucocorticoidsIBA
08/2000
1Immunoglobulin G (IgG)IBA
08/2000
1Quinine (Quinson)FDA Link
08/2000
1Atovaquone (Mepron)FDA Link
08/2000
1Procarbazine (Matulane)FDA Link
03/2000
1Vinblastine (Vinblastine Sulfate)FDA Link
03/2000
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2000
1Dacarbazine (DIC)FDA LinkGeneric
03/2000
1C-Reactive ProteinIBA
02/2000

Therapy/Procedure

7Drug Therapy (Chemotherapy)
06/2011 - 01/2000
4Therapeutics
11/2009 - 02/2000
2Analgesia
01/2005 - 04/2001
2Combination Drug Therapy (Combination Chemotherapy)
05/2001 - 03/2000
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2015
1Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
12/2015
1Controlled Hypotension
08/2013
1Debridement
04/2010
1Hematopoietic Stem Cell Transplantation
11/2009
1Pleurodesis
10/2005
1Ligation
01/2005
1Nerve Block (Nerve Blocks)
09/2001
1Complementary Therapies (Alternative Medicine)
09/2001
1Radiotherapy
09/2001
1Blood Transfusion (Blood Transfusions)
08/2000
1COPP protocol
03/2000